日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Intraperitoneal infusion of NKG2D CAR-NK cells induces endogenous CD8(+) T cell activation in patients with advanced colorectal cancer.

腹腔内输注 NKG2D CAR-NK 细胞可诱导晚期结直肠癌患者体内内源性 CD8(+) T 细胞活化

Li Bin, Zhu Xudong, Ge Jingyu, Zhang Hangyu, Gao Yang, Bao Xuanwen, Dai Xiaomeng, Du Zhicheng, Tu Xiaoxuan, Tong Zhou, Fu Qihan, Hu Dongxue, Tian Weihong, Zheng Yi, Liu Lulu, Zhao Peng, Fang Weijia, Wang Shu, Wang Dongrui

Construction of an artificially intelligent model for accurate detection of HCC by integrating clinical, radiological, and peripheral immunological features

构建一种整合临床、影像学和外周免疫学特征的人工智能模型,用于准确检测肝细胞癌。

Wang, Yangyang; Chi, Shengqiang; Tian, Yu; Li, Xueyao; Zhang, Hang; Xu, Yiting; Huang, Chao; Gao, Yiwei; Jin, Gaowei; Fu, Qihan; Cao, Wanyue; Chen, Cao; Ding, Haonan; Zhang, Yuquan; Hong, Yupeng; Li, Junjian; Sun, Xu; Li, Enliang; Zhang, Yuhua; Yao, Weiyun; Liu, Runtian; Hua, Yongfei; Huang, Haifeng; Xu, Minghui; Zhang, Bo; Tao, Weifeng; Yang, Tianxing; Gao, Yuming; Wang, Xiaoguang; Lin, Cheng; Li, Jingsong; Zhang, Qi; Liang, Tingbo

Wearable fall risk assessment by discriminating recessive weak foot individual

通过识别隐性弱足个体进行可穿戴式跌倒风险评估

Song, Zhen; Ou, Jianlin; Wu, Shibin; Shu, Lin; Fu, Qihan; Xu, Xiangmin

Oxaliplatin plus irinotecan vs irinotecan as second-line treatment in pancreatic cancer patients: a randomized-controlled open-label Phase II study

奥沙利铂联合伊立替康对比伊立替康单药治疗胰腺癌二线治疗:一项随机对照开放标签II期研究

Zhang, Hangyu; Tong, Zhou; Liu, Lulu; Fu, Qihan; Zhu, Xudong; Dai, Xiaomeng; Bao, Xuanwen; Fang, Weijia; Zheng, Yi; Zhao, Peng

Case Report: Partial response to single-agent pembrolizumab in a chemotherapy-resistant metastatic pancreatic cancer patient with a high tumor mutation burden

病例报告:一例化疗耐药、肿瘤突变负荷高的转移性胰腺癌患者,单药帕博利珠单抗治疗后获得部分缓解

Dai, Mengyao; Sheng, Jianpeng; Zhang, Qi; Wang, Jianxin; Fu, Qihan; Liang, Tingbo

Immunotherapy for targeting cancer stem cells in hepatocellular carcinoma

针对肝细胞癌中癌干细胞的免疫疗法

Dai, Xiaomeng; Guo, Yixuan; Hu, Yan; Bao, Xuanwen; Zhu, Xudong; Fu, Qihan; Zhang, Hangyu; Tong, Zhou; Liu, Lulu; Zheng, Yi; Zhao, Peng; Fang, Weijia

CAR-based cell therapy: evaluation with bibliometrics and patent analysis

基于CAR的细胞疗法:文献计量学和专利分析评价

Yuan, Yajun; Fu, Qihan; Zhang, Yaqun; Xu, Danhai; Wu, Yeqing; Qiu, Qiufei; Zhou, Wuyuan

Anti-PD-1/PD-L1 Blockade Immunotherapy Employed in Treating Hepatitis B Virus Infection-Related Advanced Hepatocellular Carcinoma: A Literature Review

抗PD-1/PD-L1阻断免疫疗法在治疗乙型肝炎病毒感染相关晚期肝细胞癌中的应用:文献综述

Li, Bin; Yan, Cong; Zhu, Jiamin; Chen, Xiaobing; Fu, Qihan; Zhang, Hangyu; Tong, Zhou; Liu, Lulu; Zheng, Yi; Zhao, Peng; Jiang, Weiqin; Fang, Weijia

Dynamic alterations of genome and transcriptome in KRAS G13D mutant CRC PDX model treated with cetuximab

西妥昔单抗治疗KRAS G13D突变型CRC PDX模型后基因组和转录组的动态变化

Zhang, Hangyu; Yuan, Liyun; Liu, Lulu; Yan, Cong; Cheng, Jinming; Fu, Qihan; Tong, Zhou; Jiang, Weiqin; Zheng, Yi; Zhao, Peng; Zhang, Guoqing; Fang, Weijia

Molecular Profiling-Based Precision Medicine in Cancer: A Review of Current Evidence and Challenges

基于分子谱的癌症精准医疗:现有证据与挑战综述

Zhang, Qi; Fu, Qihan; Bai, Xueli; Liang, Tingbo